Skip to main content

Expanding Methadone Access in Correctional Facilities

Published

On March 28, 2024, the Johns Hopkins Center for Mental Health and Addiction Policy and the White House Office of National Drug Control Policy hosted a forum about recent rules and guidance issued by the Substance Abuse & Mental Health Services Administration (SAMHSA) on the use of methadone in correctional facilities and the concurrent roll-out of federal initiatives increasing access to treatment. We're proud to present the program in full here, including panel discussions with policymakers and practitioners at the federal, state and local levels.

 

 

Featured speakers included: 

Rahul Gupta, MD, MPH, FACP, MBA 

Director of the White House Office of National Drug Control Policy (ONDCP) 

Brendan Saloner, PhD 

Bloomberg Professor of American Health

Johns Hopkins Bloomberg School of Public Health 

Yngvild Olsen, MD, MPH 

Director of the Center for Substance Abuse Treatment (CSAT) 

Substance Abuse & Mental Health Services Administration (SAMHSA) 

Matthew Strait, MA 

Deputy Assistant Administrator

Office of Diversion Control Regulatory (DCR) 

Drug Enforcement Administration (DEA) 

Sara Whaley, MPH, MSW, MA 

Senior Practice Associate 

Johns Hopkins Bloomberg School of Public Health 

Catherine Smith, DO 

Director of Addiction Medicine 

Washington State Department of Corrections 

Ryan Thornell, PhD 

Director 

Arizona Department of Corrections Rehabilitation and Reentry

 

For more information about how access to methadone treatment can be implemented in carceral settings, check out these links: